AusBiotech is calling for leadership articles to include in the September 2022 edition of the Australasian Biotechnology journal.
AusBiotech is welcoming abstracts from valued members on three set themes:
- Australian commercialisation successes;
- Investment trends and ventures;
- Incubators and accelerators; and,
- Who’s who and what’s the latest.
The journal will also feature a sneak-peek into AusBiotech 2022 and AusBioInvest 2022, AusBiotech’s premier life sciences and investment conferences taking place on 26-28 October in Perth, WA, where key stakeholders of the Australian and international biotechnology and therapeutics sectors come together to engage and propel the sector.
Australasian Biotechnology is AusBiotech’s official bi-annual journal and is published in April and September. Its contributions are by industry, for the industry.
With its informed and authoritative editorials, Australasian Biotechnology is a highly-effective communications vehicle for those wanting to reach out to stakeholders in the life sciences sector. The journal is mailed to over 3,000 AusBiotech members and investors, as well as published digitally. Readership includes companies, government and university departments, research institutes, and biotechnology and professional services providers nationally, and in key overseas markets.
Two-hundred-word abstracts on your proposed topic, or questions, can be sent to the AusBiotech Communications team by 24 June 2022 (accepted articles due by 15 July 2022).
Download your copy of the April 2022 edition, here.